Search results

Slaughter and May advised Reckitt Benckiser Group plc on the establishment of an EMTN programme and subsequent issuances Slaughter and May advised Reckitt Benckiser Group plc on the establishment of an EMTN programme and subsequent issuances Slaughter and May is advising Aviva on the acquisition of AIG's UK protection business Slaughter and May is advising Aviva on the acquisition of AIG's UK protection business Slaughter and May advised MTR Corporation Limited on its issuance of HKD150 million 4.6% Fixed Rate Notes due 14 September 2025 Slaughter and May, Hong Kong, advised MTR Corporation Limited on its issuance of HKD150 million 4.6% Fixed Rate Notes due 14 September 2025 (the Notes) Slaughter and May advised MTR Corporation Limited on its issuance of HKD150 million 4.72% Fixed Rate Notes due 19 September 2025 Slaughter and May, Hong Kong, advised MTR Corporation Limited on its issuance of HKD150 million 4.72% Fixed Rate Notes due 19 September 2025 Slaughter and May advised MTR on the KWU Tung station and Tuen Mun south extension projects Slaughter and May advised MTR on the KWU Tung station and Tuen Mun south extension projects Slaughter and May advised MTR Corporation Limited on its issuance of HKD900 million fixed rate notes Slaughter and May advised MTR Corporation Limited on its issuance of HKD900 million fixed rate notes Slaughter and May advised CMB International Capital on the USD51 million issuance and sale of shares of Shandong Fengxiang Co., Ltd Slaughter and May, Hong Kong, advised CMB International Capital on the USD51 million issuance and sale of shares of Shandong Fengxiang Co., Ltd Slaughter and May are advising DMG Media on its proposed joint venture with News UK Slaughter and May are advising DMG Media on its proposed joint venture with News UK Slaughter and May is advising The Restaurant Group plc on its recommended cash acquisition by Apollo Slaughter and May is advising The Restaurant Group plc on its recommended cash acquisition by Apollo Slaughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin Slaughter and May is advising Orchard Therapeutics on its recommended cash acquisition by Kyowa Kirin